WELL Health Technologies (WELL) Stock Price, News & Analysis

Company Overview

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services - Primary includes clinical operations and allied health. Omni-channel Patient Services - Specialized comprises CRH and MyHealth under two segments. Virtual Services include EMR, billing and revenue cycle management solutions, digital apps, and cybersecurity.

Key Stats

• Today's Range: C$4.56 to C$4.74
• 50-Day Range: C$4.23 to C$5.02
• 52-Week Range: C$3.68 to C$7.36
• Volume: 1.51 million shs
• Average Volume: 934,754 shs
• Market Capitalization: C$1.19 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$8.08
• Consensus Rating: Moderate Buy

WELL Health Technologies Stock Analysis - MarketRank™

WELL Health Technologies scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

WELL Health Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

WELL Health Technologies has a consensus price target of C$8.08, representing about 71.8% upside from its current price of C$4.70.

Amount of Analyst Coverage

WELL Health Technologies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of WELL Health Technologies is -9.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of WELL Health Technologies is -9.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for WELL Health Technologies, their PEG ratio cannot be calculated.

Price to Book Value per Share Ratio

WELL Health Technologies has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for WELL.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

WELL Health Technologies does not currently pay a dividend.

Dividend Growth

WELL Health Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for WELL.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.39

News Sentiment

WELL Health Technologies has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for WELL Health Technologies this week, compared to 2 articles on an average week.

Search Interest

30 people have searched for WELL on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.

MarketBeat Follows

1 people have added WELL Health Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, WELL Health Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$71,250.00 in company stock.

Percentage Held by Insiders

Only 6.80% of the stock of WELL Health Technologies is held by insiders.

Percentage Held by Institutions

Only 5.46% of the stock of WELL Health Technologies is held by institutions.

WELL Stock Analysis - Frequently Asked Questions

How have WELL shares performed this year?

WELL Health Technologies' stock was trading at C$6.86 at the beginning of 2025. Since then, WELL stock has decreased by 31.5% and is now trading at C$4.70.

How do I buy shares of WELL Health Technologies?

Shares of WELL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of WELL Health Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that WELL Health Technologies investors own include Enbridge (ENB), NVIDIA (NVDA), Meta Platforms (META), Suncor Energy (SU), Toronto-Dominion Bank (TD), Shopify (SHOP) and PayPal (PYPL).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Trading
• Current Symbol: TSE:WELL
• CIK: N/A
• Web: www.well.company
• Phone: 604 628 7266
• Fax: N/A
• Employees: 510
• Year Founded: N/A

Price Target and Rating

• Average Price Target for WELL Health Technologies: C$8.08
• High Price Target: C$11.00
• Low Price Target: C$5.00
• Potential Upside/Downside: +71.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 15.66
• P/E Growth: -1.93
• Net Income: C$73.76 million
• Net Margins: 7.67%
• Pretax Margin: N/A
• Return on Equity: 8.74%
• Return on Assets: 2.07%

Debt

• Debt-to-Equity Ratio: 46.79
• Current Ratio: 1.14
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: C$1.12 billion
• Price / Sales: 1.06
• Cash Flow: C$0.38 per share
• Price / Cash Flow: 12.27
• Book Value: C$3.69 per share
• Price / Book: 1.27

Miscellaneous

• Outstanding Shares: 253,676,000
• Free Float: N/A
• Market Cap: C$1.19 billion
• Optionable: Not Optionable
• Beta: 1.05